{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:03:38Z","timestamp":1782302618200,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["AMED JP24fk0210103h0003"],"award-info":[{"award-number":["AMED JP24fk0210103h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI","award":["22K15971"],"award-info":[{"award-number":["22K15971"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00535-024-02195-8","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:51:51Z","timestamp":1733950311000},"page":"479-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion"],"prefix":"10.1007","volume":"60","author":[{"given":"Naotaka","family":"Kugiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rin","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Uramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunpei","family":"Hashigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2473-6966","authenticated-orcid":false,"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"issue":"3","key":"2195_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363 (Epub 20240404).","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2195_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851\u201362.","journal-title":"JAMA"},{"issue":"11","key":"2195_CR3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"8","key":"2195_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","volume":"9","author":"M Erkan","year":"2012","unstructured":"Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9(8):454\u201367 (Epub 20120619).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2195_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0927-5","author":"D Thomas","year":"2019","unstructured":"Thomas D, Radhakrishnan P. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Mol Cancer. 2019. https:\/\/doi.org\/10.1186\/s12943-018-0927-5.","journal-title":"Mol Cancer"},{"issue":"2","key":"2195_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163(2):386-402 e1 (Epub 20220407).","journal-title":"Gastroenterology"},{"key":"2195_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.655152","author":"X Geng","year":"2021","unstructured":"Geng X, Chen H, Zhao L, Hu J, Yang W, Li G, et al. Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.655152.","journal-title":"Front Cell Dev Biol"},{"issue":"16","key":"2195_CR8","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res. 2012;18(16):4266\u201376.","journal-title":"Clin Cancer Res"},{"key":"2195_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02599-7","author":"B Feng","year":"2022","unstructured":"Feng B, Wu J, Shen B, Jiang F, Feng J. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell Int. 2022. https:\/\/doi.org\/10.1186\/s12935-022-02599-7.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"2195_CR10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res. 2023;29(6):1009\u201316.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2195_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147\u201376 (Epub 20200528).","journal-title":"Physiol Rev"},{"issue":"3","key":"2195_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"8","key":"2195_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102\u201323 (Epub 20190613).","journal-title":"Cancer Discov"},{"key":"2195_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910515","author":"H Huang","year":"2019","unstructured":"Huang H, Zhang Y, Gallegos V, Sorrelle N, Zaid MM, Toombs J, et al. Targeting TGF\u03b2R2-mutant tumors exposes vulnerabilities to stromal TGF\u03b2 blockade in pancreatic cancer. EMBO Mol Med. 2019. https:\/\/doi.org\/10.15252\/emmm.201910515.","journal-title":"EMBO Mol Med"},{"issue":"40","key":"2195_CR15","doi-asserted-by":"publisher","first-page":"65982","DOI":"10.18632\/oncotarget.11786","volume":"7","author":"NS Nagathihalli","year":"2016","unstructured":"Nagathihalli NS, Castellanos JA, VanSaun MN, Dai X, Ambrose M, Guo Q, et al. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells. Oncotarget. 2016;7(40):65982\u201392.","journal-title":"Oncotarget"},{"key":"2195_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, Ito K, Matsuda A, Sekiya S, et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065 (Epub 20130115).","journal-title":"Sci Rep"},{"issue":"12","key":"2195_CR17","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s00535-023-02043-1","volume":"58","author":"H Uojima","year":"2023","unstructured":"Uojima H, Nakabayashi K, Yamasaki K, Sugiyama M, Ishii N, Shirabe K, et al. New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease. J Gastroenterol. 2023;58(12):1252\u201360 (Epub 20231008).","journal-title":"J Gastroenterol"},{"issue":"7","key":"2195_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00535-024-02100-3","volume":"59","author":"H Uojima","year":"2024","unstructured":"Uojima H, Yamasaki K, Sugiyama M, Kage M, Ishii N, Shirabe K, et al. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation. J Gastroenterol. 2024;59(7):598\u2013608 (Epub 20240416).","journal-title":"J Gastroenterol"},{"issue":"10","key":"2195_CR19","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/glycob\/cwab060","volume":"31","author":"E Noro","year":"2021","unstructured":"Noro E, Matsuda A, Kyoutou T, Sato T, Tomioka A, Nagai M, et al. N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis. Glycobiology. 2021;31(10):1268\u201378.","journal-title":"Glycobiology"},{"issue":"7","key":"2195_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/jgh.13708","volume":"32","author":"Y Bekki","year":"2017","unstructured":"Bekki Y, Yoshizumi T, Shimoda S, Itoh S, Harimoto N, Ikegami T, et al. Hepatic stellate cells secreting WFA(+) -M2BP: its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol. 2017;32(7):1387\u201393.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"2195_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41416-020-0971-y","volume":"123","author":"G Dolgormaa","year":"2020","unstructured":"Dolgormaa G, Harimoto N, Ishii N, Yamanaka T, Hagiwara K, Tsukagoshi M, et al. Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling. Br J Cancer. 2020;123(7):1145\u201353.","journal-title":"Br J Cancer"},{"issue":"7","key":"2195_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00535-017-1425-z","volume":"53","author":"K Shirabe","year":"2018","unstructured":"Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53(7):819\u201326.","journal-title":"J Gastroenterol"},{"key":"2195_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.rmed.2016.04.013","volume":"115","author":"M Kono","year":"2016","unstructured":"Kono M, Nakamura Y, Oyama Y, Mori K, Hozumi H, Karayama M, et al. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis. Respir Med. 2016;115:46\u201352.","journal-title":"Respir Med"},{"issue":"5","key":"2195_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/1751-2980.12475","volume":"18","author":"T Fujiyama","year":"2017","unstructured":"Fujiyama T, Ito T, Ueda K, Tachibana Y, Yasunaga K, Miki M, et al. Serum levels of Wisteria floribunda agglutinin-positive Mac-2 binding protein reflect the severity of chronic pancreatitis. J Dig Dis. 2017;18(5):302\u20138.","journal-title":"J Dig Dis"},{"issue":"6","key":"2195_CR25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.pan.2016.09.003","volume":"16","author":"Y Waragai","year":"2016","unstructured":"Waragai Y, Suzuki R, Takagi T, Sugimoto M, Asama H, Watanabe K, et al. Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma. Pancreatology. 2016;16(6):1044\u201350 (Epub 2016\/09\/26).","journal-title":"Pancreatology"},{"issue":"4","key":"2195_CR26","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/cas.16087","volume":"115","author":"T Yamanaka","year":"2024","unstructured":"Yamanaka T, Araki K, Yokobori T, Muranushi R, Hoshino K, Hagiwara K, et al. Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer Sci. 2024;115(4):1241\u20139.","journal-title":"Cancer Sci"},{"issue":"5","key":"2195_CR27","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1245\/s10434-019-07266-2","volume":"26","author":"T Yamao","year":"2019","unstructured":"Yamao T, Yamashita Y-I, Yamamura K, Nakao Y, Tsukamoto M, Nakagawa S, et al. Cellular senescence, represented by expression of caveolin-1, in cancer-associated fibroblasts promotes tumor invasion in pancreatic cancer. Ann Surg Oncol. 2019;26(5):1552\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2195_CR28","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/s41467-019-11415-2","volume":"10","author":"K Yu","year":"2019","unstructured":"Yu K, Chen B, Aran D, Charalel J, Yau C, Wolf DM, et al. Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. Nat Commun. 2019;10(1):3574 (Epub 20190808).","journal-title":"Nat Commun"},{"issue":"4","key":"2195_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, Kim J, Yang S, Wang H, Wu C-J, Sugimoto H, et al. Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell. 2021;39(4):548-65.e6.","journal-title":"Cancer Cell"},{"issue":"10","key":"2195_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00535-023-02020-8","volume":"58","author":"S Ashina","year":"2023","unstructured":"Ashina S, Masuda A, Yamakawa K, Hamada T, Tsujimae M, Tanaka T, et al. A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma. J Gastroenterol. 2023;58(10):1055\u201367 (Epub 20230721).","journal-title":"J Gastroenterol"},{"issue":"2","key":"2195_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9(2):282\u2013301.","journal-title":"Cancer Discov"},{"key":"2195_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122601","author":"SY Park","year":"2017","unstructured":"Park SY, Yoon S, Sun EG, Zhou R, Bae JA, Seo YW, et al. Glycoprotein 90K promotes E-cadherin degradation in a cell density-dependent manner via dissociation of E-cadherin-p120-catenin complex. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18122601. (Epub 20171202).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2195_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12967-021-03085-w","volume":"19","author":"E Capone","year":"2021","unstructured":"Capone E, Iacobelli S, Sala G. Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target. J Transl Med. 2021;19(1):405 (Epub 20210926).","journal-title":"J Transl Med"},{"issue":"2","key":"2195_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ijc.23970","volume":"124","author":"N Tinari","year":"2009","unstructured":"Tinari N, Lattanzio R, Querzoli P, Natoli C, Grassadonia A, Alberti S, et al. High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies. Int J Cancer. 2009;124(2):333\u20138.","journal-title":"Int J Cancer"},{"issue":"1","key":"2195_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/ijo.2016.3521","volume":"49","author":"N Woodman","year":"2016","unstructured":"Woodman N, Pinder SE, Tajadura V, Le Bourhis X, Gillett C, Delannoy P, et al. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer. Int J Oncol. 2016;49(1):265\u201375 (Epub 20160513).","journal-title":"Int J Oncol"},{"issue":"9","key":"2195_CR36","first-page":"2535","volume":"62","author":"A Marchetti","year":"2002","unstructured":"Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res. 2002;62(9):2535\u20139.","journal-title":"Cancer Res"},{"issue":"3","key":"2195_CR37","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/pr4010184","volume":"13","author":"S Pan","year":"2014","unstructured":"Pan S, Chen R, Tamura Y, Crispin DA, Lai LA, May DH, et al. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res. 2014;13(3):1293\u2013306 (Epub 20140128).","journal-title":"J Proteome Res"},{"key":"2195_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201700064","author":"EN Nigjeh","year":"2017","unstructured":"Nigjeh EN, Chen R, Allen-Tamura Y, Brand RE, Brentnall TA, Pan S. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteom Clin Appl. 2017. https:\/\/doi.org\/10.1002\/prca.201700064. (Epub 20170710).","journal-title":"Proteom Clin Appl"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-024-02195-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T08:12:20Z","timestamp":1742371940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-024-02195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1007\/s00535-024-02195-8","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board of Kumamoto University (acceptance number 2458), and all patients provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}